Haemonetics to Present at Raymond James 45th Annual Institutional Investors Conference

BOSTON, Feb. 21, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will participate in a fireside chat with investors at the Raymond James 45th Annual Institutional Investors Conference on Tuesday, March 5, 2024 at 7:30 a.m. ET.

The public may access a live webcast of the fireside chat at Haemonetics' Investor Relations website or at the following link: https://wsw.com/webcast/rj129/hae/1445840. A replay of the recorded webcast will become accessible 12 hours after the event and will be available for 90 days on Haemonetics' Investor Relations website.

About Haemonetics

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.

     
              Investor Contacts:



     Olga Guyette, Sr. Director-Investor Relations & Treasury   David Trenk, Manager-Investor
                                                                  Relations



     (781) 356-9763                                           
     (203) 733-4987



     
              olga.guyette@haemonetics.com                               david.trenk@haemonetics.com





     
              Media Contact:



     Josh Gitelson, Director-Global Communications



     (781) 356-9776



     
              josh.gitelson@haemonetics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-to-present-at-raymond-james-45th-annual-institutional-investors-conference-302068095.html

SOURCE Haemonetics Corporation